Basic Information
ID: ALA3074876
Type: Functional
Description: Antiviral activity against Human immunodeficiency virus 1 infected human MT4 cells assessed as protection against virus-induced cytopathogenicity treated before viral infection measured after 4 days by MTT assay
Organism: Human immunodeficiency virus 1
Cell type: MT4
Activity Charts
Bioactivity
Activity Types for Assay ALA3074876
EC50
Compound Summary
| Parent Molecular Weight | ALogP | Polar Surface Area |
|---|---|---|
| 267.24 | -0.20 | -0.20 |
| 346.35 | 2.84 | 2.84 |
| 316.32 | 2.83 | 2.83 |
| 332.39 | 3.54 | 3.54 |
| 365.19 | 3.58 | 3.58 |
| 304.29 | 2.96 | 2.96 |
| 320.74 | 3.47 | 3.47 |
| 320.74 | 3.47 | 3.47 |
| 331.30 | 2.73 | 2.73 |
| 331.30 | 2.73 | 2.73 |
| 286.30 | 2.82 | 2.82 |
| 331.30 | 2.73 | 2.73 |
| 378.40 | 4.61 | 4.61 |
| 346.35 | 2.84 | 2.84 |
| 316.32 | 2.83 | 2.83 |
| 316.32 | 2.83 | 2.83 |
| 320.74 | 3.47 | 3.47 |
| 302.30 | 2.53 | 2.53 |
| 302.30 | 2.53 | 2.53 |
| 302.30 | 2.53 | 2.53 |
| 332.32 | 2.54 | 2.54 |
| 300.33 | 3.13 | 3.13 |
| 392.47 | 4.64 | 4.64 |